PDCD1 and cancer: It is possible that the disruption of the PD-1/PD-L1 axis mediated by anti-PD-1 antibody might determine a reactivation of these cells with a consequent release of cytokines that, as already mentioned, can have protumor activity in certain types of cancers [45, 46].